20th Gordon L. Snider Critical Issues Workshop – The Promise of Gene-based Interventions in Alpha-1 Antitrypsin Deficiency

Investors

20th Gordon L. Snider Critical Issues Workshop – The Promise of Gene-based Interventions in Alpha-1 Antitrypsin Deficiency

Dec 12, 2020 12:55 PM EST

James Hamilton, M.D., MBA, Arrowhead’s senior vice president of discovery and translational medicine, will deliver an oral presentation titled, “Arrowhead’s approach to gene silencing - ARO-AAT for liver disease in Alpha-1 antitrypsin deficiency”

Supporting Materials